COMPANY
GeneCopoeia
Service / Tools company
NIH awards 5
- NIH award 5R44CA124001-04 FY2010: $367,754 awarded for that fiscal year; activity R44 (SBIR); PI LIN, XINLI HENRY; recipient as written: GENECOPOEIA, INC., ROCKVILLE, MD. p53 Fusion Protein as an Oncology Therapeutic source ↗
- NIH award 1R43HL102979-01 FY2010: $107,000 awarded for that fiscal year; activity R43 (SBIR); PI LIN, XINLI HENRY; recipient as written: GENECOPOEIA, INC., ROCKVILLE, MD. Recombinant alpha1-Antitrypsin Therapeutics source ↗
- NIH award 2R44CA124001-03 FY2009: $367,754 awarded for that fiscal year; activity R44 (SBIR); PI LIN, XINLI HENRY; recipient as written: GENECOPOEIA, INC., ROCKVILLE, MD. p53 Fusion Protein as an Oncology Therapeutic source ↗
- NIH award 1R43HL097388-01 FY2009: $106,998 awarded for that fiscal year; activity R43 (SBIR); PI LIN, XINLI HENRY; recipient as written: GENECOPOEIA, INC., ROCKVILLE, MD. Mutant miniPlasmin for Treatment of Periphera source ↗
- NIH award 7R43CA124001-02 FY2007: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI LIN, XINLI HENRY; recipient as written: GENECOPOEIA, INC., ROCKVILLE, MD. p53 Fusion Protein as an Oncology Therapeutic source ↗